News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,232 Results
Type
Article (43704)
Company Profile (350)
Press Release (673178)
Section
Business (212103)
Career Advice (2175)
Deals (37064)
Drug Delivery (108)
Drug Development (84045)
Employer Resources (173)
FDA (16648)
Job Trends (15542)
News (359455)
Policy (34358)
Tag
Academia (2608)
Alliances (51904)
Alzheimer's disease (1319)
Approvals (16597)
Artificial intelligence (184)
Bankruptcy (370)
Best Places to Work (11809)
Biotechnology (221)
Breast cancer (209)
Cancer (1585)
Cardiovascular disease (134)
Career advice (1809)
CAR-T (114)
Cell therapy (326)
Clinical research (67399)
Collaboration (607)
Compensation (317)
COVID-19 (2645)
C-suite (137)
Data (1491)
Diabetes (202)
Diagnostics (6318)
Earnings (87162)
Employer resources (152)
Events (114434)
Executive appointments (506)
FDA (17440)
Funding (533)
Gene therapy (231)
GLP-1 (699)
Government (4529)
Healthcare (19070)
Infectious disease (2749)
Inflammatory bowel disease (120)
Interviews (338)
IPO (16831)
Job creations (4158)
Job search strategy (1551)
Layoffs (462)
Legal (8482)
Lung cancer (236)
Manufacturing (232)
Medical device (13370)
Medtech (13375)
Mergers & acquisitions (20490)
Metabolic disorders (552)
Neuroscience (1705)
NextGen: Class of 2025 (6720)
Non-profit (4547)
Northern California (1887)
Obesity (318)
Opinion (230)
Patents (141)
People (59141)
Phase I (20990)
Phase II (29615)
Phase III (22176)
Pipeline (625)
Postmarket research (2683)
Preclinical (8839)
Radiopharmaceuticals (248)
Rare diseases (307)
Real estate (6353)
Regulatory (22985)
Research institute (2385)
Resumes & cover letters (370)
Southern California (1628)
Startups (3784)
United States (17005)
Vaccines (612)
Weight loss (241)
Date
Today (120)
Last 7 days (437)
Last 30 days (2005)
Last 365 days (35734)
2025 (1876)
2024 (36189)
2023 (40930)
2022 (52113)
2021 (56674)
2020 (55111)
2019 (47824)
2018 (36140)
2017 (33570)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (804)
Arizona (212)
Asia (41251)
Australia (6546)
California (4306)
Canada (1573)
China (375)
Colorado (196)
Connecticut (209)
Europe (88230)
Florida (617)
Georgia (147)
Illinois (428)
Indiana (255)
Maryland (704)
Massachusetts (3358)
Michigan (185)
Minnesota (321)
New Jersey (1215)
New York (1214)
North Carolina (835)
Northern California (1887)
Ohio (158)
Pennsylvania (1008)
South America (1181)
Southern California (1628)
Texas (636)
Utah (124)
Washington State (437)
717,232 Results for "recludix pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
January 10, 2025
·
1 min read
Press Releases
Recludix Pharma to Participate in Two Investor Conferences in December
November 25, 2024
·
1 min read
Biotech Beach
Recludix Pharma to Participate in Two Investor Conferences in March 2024
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, announced that members of Recludix’s management will host meetings at two investor conferences in March.
February 28, 2024
·
1 min read
Biotech Beach
Recludix Pharma to Present at Two Investor Conferences in February
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in February.
February 6, 2024
·
1 min read
Press Releases
Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis
November 14, 2024
·
4 min read
Biotech Beach
Recludix Pharma to Present at Two Investor Conferences in November 2023
Recludix Pharma announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in November.
November 9, 2023
·
1 min read
Biotech Beach
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and Safety in Preclinical Models of Th17 Mediated Skin Inflammation in Oral Plenary Session at SID Annual Meeting
Recludix Pharma presented new data today in an oral plenary presentation at the Society for Investigative Dermatology (SID) Annual Meeting titled “Oral selective STAT3 inhibitors demonstrate differentiated efficacy and safety potential in preclinical models of Th17 mediated skin inflammation” (abstract #738).
May 17, 2024
·
4 min read
Business
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive VP and Head of Research & Development, and Strengthens Scientific Advisory Board with the Addition of Dr. Adrian Ray
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, announced the appointment of Ajay Nirula, M.D., Ph.D., as the company’s executive vice president and head of research and development, and the addition of Adrian S. Ray, Ph.D., to its scientific advisory board.
April 23, 2024
·
5 min read
Press Releases
Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
August 5, 2024
·
4 min read
Biotech Beach
Recludix Pharma to Participate in Multiple Investor Conferences in September 2023
Recludix Pharma announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at multiple investor conferences in September.
August 30, 2023
·
1 min read
1 of 71,724
Next
